296 related articles for article (PubMed ID: 8672026)
1. Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.
Erdem Y; Haznedaroglu IC; Celik I; Yalcin AU; Yasavul U; Turgan C; Caglar S
Nephrol Dial Transplant; 1996 Jul; 11(7):1299-305. PubMed ID: 8672026
[TBL] [Abstract][Full Text] [Related]
2. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
3. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
Sindet-Pedersen S
Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
[TBL] [Abstract][Full Text] [Related]
4. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
5. The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis.
Sabovic M; Salobir B; Preloznik Zupan I; Bratina P; Bojec V; Buturovic Ponikvar J
Pathophysiol Haemost Thromb; 2005; 34(6):274-8. PubMed ID: 16772739
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
7. Haemostatic complications in haemodialysis patients: effect of type of vascular access and dialysis filter.
Yu A; Egberg N; Jacobson SH
Scand J Clin Lab Invest; 2003; 63(2):127-33. PubMed ID: 12751694
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the pro-thrombotic state in CAPD patients.
Preloznik Zupan I; Sabovic M; Salobir B; Buturovic Ponikvar J
Ren Fail; 2008; 30(6):597-602. PubMed ID: 18661409
[TBL] [Abstract][Full Text] [Related]
9. Systemic coagulation and fibrinolysis in patients with or at risk for the adult respiratory distress syndrome.
Groeneveld AB; Kindt I; Raijmakers PG; Hack CE; Thijs LG
Thromb Haemost; 1997 Dec; 78(6):1444-9. PubMed ID: 9423792
[TBL] [Abstract][Full Text] [Related]
10. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
Uchida Y
Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
[TBL] [Abstract][Full Text] [Related]
11. [Dysfunction of fibrinolysis as a risk factor of thrombosis].
Kołodziejczyk J; Wachowicz B
Pol Merkur Lekarski; 2009 Oct; 27(160):341-5. PubMed ID: 19928667
[TBL] [Abstract][Full Text] [Related]
12. Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine.
Bonomini M; Sirolli V; Merciaro G; Antidormi T; Di Liberato L; Brummer U; Papponetti M; Cappelli P; Di Gregorio P; Arduini A
Nephrol Dial Transplant; 2005 Feb; 20(2):361-6. PubMed ID: 15598665
[TBL] [Abstract][Full Text] [Related]
13. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].
Opatrný K; Vít L; Opatrná S; Sulková S; Bodláková B
Cas Lek Cesk; 1994 May; 133(11):346-9. PubMed ID: 8004664
[TBL] [Abstract][Full Text] [Related]
14. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
16. Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy.
Małyszko J; Małyszko JS; Hryszko T; Myśliwiec M
Thromb Haemost; 2004 Mar; 91(3):480-6. PubMed ID: 14983223
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
18. [Relation between the blood coagulation status in hemodialyzed patients and arteriovenous fistula thrombosis--prospective study].
Charvát J; Kestlerová M; Jarosová H; Mlejnková M
Cas Lek Cesk; 1994 Apr; 133(8):242-4. PubMed ID: 8194088
[TBL] [Abstract][Full Text] [Related]
19. Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients.
Pawlak K; Zolbach K; Borawski J; Mysliwiec M; Kovalchuk O; Chyczewski L; Pawlak D
Thromb Res; 2008; 123(1):166-70. PubMed ID: 18452978
[TBL] [Abstract][Full Text] [Related]
20. Recombinant tissue plasminogen activator (rt-PA) as first-line therapy for declotting of haemodialysis access.
Andriani M; Drago G; Bernardi AM; Da Porto A; De Luca M; Riegler P; Biasia F; Pinzani A
Nephrol Dial Transplant; 1995; 10(9):1714-9. PubMed ID: 8559494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
